Chief Financial Officer
Ken Serota is responsible for managing all financial aspects at Evozyne. Formerly he was the president of dental—a $1.5 billion division—at Cantel Medical Corporation after leading Hu-Friedy as president for 8 years culminating in its sale to Cantel. Prior to that, Ken was president and CEO of Liberty Group Publishing, a portfolio company of Leonard Green & Partners which was successfully sold to Fortress Investment Group. He is a member of the Board of Overseers of the University of Pennsylvania School of Dental Medicine and the NYU College of Dentistry Dean's Strategic Advisory Council. Ken earned a Juris Doctor from the University of Illinois College of Law and a Bachelor of Science in Accounting from the University of Illinois. He is a licensed attorney and a Certified Public Accountant.